The COVID-19 pandemic is causing a lot of complications for all the businesses worldwide. Similarly, the impacts of coronavirus are now seen in the neuro-stimulators market. Also, with the upstream and downstream of businesses stopping their operations, the supply in the market is cut-off.
Because of this reason, the supply chain market is experiencing massive losses. The report is useful for all the key players in the market who are dealing with revenue, capital investment, and consumer businesses.
Along with this, the players dealing with import and export businesses are facing a significant blow to their businesses. Also, a study shows that by the year 2026, the growth of the neuro-stimulators market is expected to be around $13 billion.
Here are certain major companies who are facing incredible losses because of the COVID-19 i.e. coronavirus impact:
- Boston Scientific Corporation
- Nevro Corp
- LivaNova PLC
- Laborie Inc.
- Saluda Media PVT. LTD.
- Biomedical Inc., and many more.
The study shows insights into the neurostimulators market based on the possibilities, growth analysis, and the future. Also, the demographics that are facing a major hit are as follows:
- North America – USA, Canada, Mexico
- Europe – Russia, France, Germany, Italy.
- Asia-Pacific – India, China, Southeast Asia.
- South America – Brazil, Argentina
- Middle-East – Nigeria, UAE, Saudi Arabia, and South Africa.
Although the market shows a dip, there is a possibility that the medical device market will see positive growth after the lockdowns will be lifted. Moreover, enlisted products are likely to witness positive growth:
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Sacral Nerve Stimulators
- Gastric Stimulators
Moreover, the market intelligence report focuses on defining the structure of the market. Furthermore, it focuses on the various other factors that are affecting the development.
In other words, the impact of coronavirus is massive.